2024 Q2 Form 10-Q Financial Statement
#000168316824003162 Filed on May 09, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| Revenue | $12.50M | $1.500M | $0.00 |
| YoY Change | -100.0% | ||
| Cost Of Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Gross Profit | $12.50M | $1.500M | $0.00 |
| YoY Change | -100.0% | ||
| Gross Profit Margin | 100.0% | 100.0% | |
| Selling, General & Admin | $7.400K | $4.940K | $71.47K |
| YoY Change | 122.22% | -51.71% | |
| % of Gross Profit | 0.06% | 0.33% | |
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $0.00 | $0.00 | |
| YoY Change | |||
| % of Gross Profit | 0.0% | 0.0% | |
| Operating Expenses | $7.400K | $4.940K | $71.47K |
| YoY Change | 122.22% | -51.71% | |
| Operating Profit | $12.49M | $1.495M | -$71.47K |
| YoY Change | -375253.15% | -45.33% | |
| Interest Expense | -$14.70K | $29.64K | -$10.98K |
| YoY Change | |||
| % of Operating Profit | -0.12% | 1.98% | |
| Other Income/Expense, Net | -$14.70K | -$31.64K | |
| YoY Change | |||
| Pretax Income | $12.48M | $1.463M | -$82.45K |
| YoY Change | -375375.31% | -3.54% | |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | 0.0% | 0.0% | |
| Net Earnings | $12.48M | $1.463M | -$82.45K |
| YoY Change | -375375.31% | -3.54% | |
| Net Earnings / Revenue | 99.82% | 97.56% | |
| Basic Earnings Per Share | $0.02 | $0.00 | |
| Diluted Earnings Per Share | $0.02 | $0.00 | $0.00 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 563.5M shares | 507.9M shares | 501.5M shares |
| Diluted Shares Outstanding | 507.9M shares | 507.9M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $14.16M | $1.645M | $175.0K |
| YoY Change | 370.3% | ||
| Cash & Equivalents | $155.7K | $145.4K | $175.0K |
| Short-Term Investments | $14.00M | $1.500M | |
| Other Short-Term Assets | $14.00M | $1.500M | $0.00 |
| YoY Change | -100.0% | ||
| Inventory | $46.15K | $0.00 | $46.15K |
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $14.27M | $1.756M | $285.3K |
| YoY Change | 62134.07% | 10011.95% | |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | |||
| YoY Change | |||
| Goodwill | $806.2K | $806.2K | $806.2K |
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $2.500M | $2.500M | $0.00 |
| YoY Change | |||
| Total Long-Term Assets | $9.306M | $9.306M | $6.806M |
| YoY Change | |||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $14.27M | $1.756M | $285.3K |
| Total Long-Term Assets | $9.306M | $9.306M | $6.806M |
| Total Assets | $23.57M | $11.06M | $7.091M |
| YoY Change | 392022.69% | 251279.51% | |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $177.6K | $150.7K | $143.7K |
| YoY Change | 4.56% | ||
| Accrued Expenses | |||
| YoY Change | |||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $114.2K | $114.2K | $114.2K |
| YoY Change | |||
| Total Short-Term Liabilities | $291.7K | $264.8K | $257.9K |
| YoY Change | 257.91% | 226.93% | 218.36% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $987.4K | $987.4K | $987.4K |
| YoY Change | |||
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $987.4K | $987.4K | $987.4K |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $291.7K | $264.8K | $257.9K |
| Total Long-Term Liabilities | $987.4K | $987.4K | $987.4K |
| Total Liabilities | $1.279M | $1.252M | $1.245M |
| YoY Change | 1469.44% | 1445.99% | 1437.42% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$401.2K | -$12.88M | -$14.34M |
| YoY Change | -64.07% | 1056.96% | 1188.43% |
| Common Stock | $56.35K | $50.85K | $50.35K |
| YoY Change | 1897.41% | 1702.45% | 1684.72% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $22.29M | $9.810M | $5.846M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $23.57M | $11.06M | $7.091M |
| YoY Change | 392022.69% | 251279.51% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $12.48M | $1.463M | -$82.45K |
| YoY Change | -375375.31% | -3.54% | |
| Depreciation, Depletion And Amortization | $0.00 | $0.00 | |
| YoY Change | |||
| Cash From Operating Activities | $10.31K | -$29.64K | -$57.20K |
| YoY Change | -465.6% | -247.73% | |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $0.00 | |
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | ||
| YoY Change | |||
| Cash From Investing Activities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | $0.00 | 0.000 |
| YoY Change | -100.0% | ||
| NET CHANGE | |||
| Cash From Operating Activities | 10.31K | -$29.64K | -57.20K |
| Cash From Investing Activities | 0.000 | $0.00 | 0.000 |
| Cash From Financing Activities | 0.000 | $0.00 | 0.000 |
| Net Change In Cash | 10.31K | -$29.64K | -57.20K |
| YoY Change | -291.11% | ||
| FREE CASH FLOW | |||
| Cash From Operating Activities | $10.31K | -$29.64K | -$57.20K |
| Capital Expenditures | $0.00 | $0.00 | |
| Free Cash Flow | $10.31K | -$29.64K | |
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
|
usd | |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
0 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
0 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
0 | usd |
| CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
508466410 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
508466410 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
503466410 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
503466410 | shares |
| CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
22637764 | usd |
| CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
20138264 | usd |
| CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-12879083 | usd |
| CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-14342505 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9809528 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5846106 | usd |
| CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
11061781 | usd |
| CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7091416 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
1500000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
0 | usd |
| CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
-0 | usd |
| CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
-0 | usd |
| CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
1500000 | usd |
| CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
0 | usd |
| CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4943 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
-0 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1495057 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
0 | usd |
| CY2024Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
0 | usd |
| CY2023Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
0 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
29635 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
-0 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-2000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
| CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-31635 | usd |
| CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1463422 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
0 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-0 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-0 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1463422 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
0 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
507916959 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
507916959 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
348210000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
348210000 | shares |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1463422 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
0 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
-1500000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
|
46154 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
|
0 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
|
-46154 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
6943 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-29635 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
0 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | usd |
| CY2024Q1 | LDSN |
Proceeds From Sale Of Subsidiaries
ProceedsFromSaleOfSubsidiaries
|
0 | usd |
| CY2023Q1 | LDSN |
Proceeds From Sale Of Subsidiaries
ProceedsFromSaleOfSubsidiaries
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
| CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
| CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-29635 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
0 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
175002 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
145367 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
29635 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
| CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
| CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
| CY2024Q1 | LDSN |
Debt Converted To Common Stock
DebtConvertedToCommonStock
|
0 | usd |
| CY2023Q1 | LDSN |
Debt Converted To Common Stock
DebtConvertedToCommonStock
|
0 | usd |
| CY2024Q1 | LDSN |
Issuance Of Common Stock For Metaverse As Long Term Assets
IssuanceOfCommonStockForMetaverseAsLongTermAssets
|
2500000 | usd |
| CY2023Q1 | LDSN |
Issuance Of Common Stock For Metaverse As Long Term Assets
IssuanceOfCommonStockForMetaverseAsLongTermAssets
|
0 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-66123 | usd |
| CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-303197 | usd |
| CY2023 | LDSN |
Shares Issued As Debt Conversion12 July2023value
SharesIssuedAsDebtConversion12July2023value
|
3482 | usd |
| CY2023 | LDSN |
Shares Issued As Debt Conversion13 July2023value
SharesIssuedAsDebtConversion13July2023value
|
1218 | usd |
| CY2023 | LDSN |
Shares Issued As Debt Conversion18 July2023value
SharesIssuedAsDebtConversion18July2023value
|
5026 | usd |
| CY2023 | LDSN |
Shares Issued As Debt Conversion31 July2023value
SharesIssuedAsDebtConversion31July2023value
|
2000 | usd |
| CY2023 | LDSN |
Shares Issued As Debt Conversion1 August2023value
SharesIssuedAsDebtConversion1August2023value
|
3500 | usd |
| CY2023 | LDSN |
Transfer To Treasury Stock15 August2023value
TransferToTreasuryStock15August2023value
|
0 | usd |
| CY2023 | LDSN |
Shares Issued At Price Stock Compensationvalue
SharesIssuedAtPriceStockCompensationvalue
|
200000 | usd |
| CY2023 | LDSN |
Treasury Stock Was Given For Purchase Of30 Movie Intelligent Properties21 September2023value
TreasuryStockWasGivenForPurchaseOf30MovieIntelligentProperties21September2023value
|
6000000 | usd |
| CY2023 | LDSN |
Shares Issued As Debt Conversion16 November2023value
SharesIssuedAsDebtConversion16November2023value
|
200 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5846106 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1463422 | usd |
| CY2024Q1 | LDSN |
Shares Issued For Purchaseof Business10 January2024value
SharesIssuedForPurchaseofBusiness10January2024value
|
2500000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9809528 | usd |
| CY2023Q2 | us-gaap |
Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
|
2821 | usd |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_849_eus-gaap--UseOfEstimates_zG0pm6cNbTF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings">l</span> <span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_86C_zg4osd6x1384">Use of estimates and assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | |
| LDSN |
Property Plant And Equipment Estimated Useful Lives1
PropertyPlantAndEquipmentEstimatedUsefulLives1
|
5 years | ||
| CY2024Q1 | us-gaap |
Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure
RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure
|
<p id="xdx_845_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_z8ncEbzDvwL2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings">l</span> <span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_861_z4eGGdl9kRUj">Revenue recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted Accounting Standards Codification (“ASC<i>”) 606 – Revenue from Contracts with Customers</i>” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%; text-align: justify"> </td> <td style="width: 2%; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | |
| CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
| CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
| CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
508466410 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
503466410 | shares |
| CY2024Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2500000 | shares |
| CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2500000 | shares |
| CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
